News
Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Al Jazeera on MSN1d
Wegovy maker Novo Nordisk warns of layoffs as competition growsNovo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be ...
Sales of Danish drugmaker Novo Nordisk's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...
Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...
The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
2dOpinion
The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.
It’s the most high-profile example yet of a controversial industry practice called preferred pharmacy networks, or PPNs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback